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Abstract— The structure of microvasculature cannot be 
resolved using standard clinical ultrasound (US) imaging 
frequencies due to the fundamental diffraction limit of US waves. 
In this work, we use a standard clinical US system to perform in 
vivo sub-diffraction imaging on a CD1, female mouse aged 8 
weeks by localizing isolated US signals from bubbles flowing 
within the ear microvasculature, and compare our results to 
optical microscopy. Furthermore, we develop a new technique to 
map blood velocity at super-resolution by tracking individual 
bubbles through the vasculature. Resolution is improved from a 
measured lateral and axial resolution of 112 µm and 94 µm 
respectively in original US data, to super-resolved images of 
microvasculature where vessel features as fine as 19 µm are 
clearly visualized. Velocity maps clearly distinguish opposing 
flow direction and separated speed distributions in adjacent 
vessels, thereby enabling further differentiation between vessels 
otherwise not spatially separated in the image. This technique 
overcomes the diffraction limit to provide a non-invasive means 
of imaging the microvasculature at super-resolution, to depths of 
many centimeters. In the future, this method could non-
invasively image pathological or therapeutic changes in the 
microvasculature at centimeter depths in vivo. 
 
Index Terms— Biomedical imaging, Microbubbles, 
Microvasculature, Ultrasonic imaging, Ultrasound, Resolution.  
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I. INTRODUCTION 
he diffraction-limited image resolution inherent to 
conventional US is unable to adequately resolve the 
microvasculature. Many microvascular diseases, such as those 
associated with diabetes [1] and coronary heart disease [2], 
exhibit architectural changes in the microvascular structure, as 
well as variations in vascular flow. Angiogenesis, the 
formation of new blood vessels from existing vasculature, also 
plays a vital role in the development of many pathologies, 
including the growth and metastasis of tumors, and is an 
important predictor of the biological behavior of certain 
cancers [3]. The microcirculation can also be an active site of 
blood flow control and metabolic activity, where variations in 
vascular blood flow can be indicative of conditions such as 
ischemia, malignancies and diabetes-related microvascular 
diseases [4]. Assessment of early changes in the 
microvasculature using US would allow early clinical 
intervention and a non-invasive means of monitoring the 
treatment of such diseases [5]-[6].  
Currently, visualization of the vasculature in clinical US can 
be achieved using microbubble contrast agents [7]-[10]. These 
are gas filled spheres of a few micrometers in size. They 
exhibit a large backscatter signal as their resonance frequency 
matches the 1 to 15 MHz range of clinical US and generally 
they do not extravasate, which makes them an ideal vascular 
contrast agent [8]. Progress has been made to image the 
vasculature using contrast agents with techniques such as 
maximum intensity persistence imaging [9] and power 
Doppler sonography [10] allowing detection of blood flow. 
However, the fundamental limitation on US resolution by 
diffraction of the transmitted and received waves means 
imaging at the micrometer scale is still required. High 
frequency US has been developed as a means of obtaining 
high-resolution imaging [11], however these techniques have 
limited application due to the inherent compromise between 
higher frequencies and limited penetration depth. 
Since microbubbles are considerably smaller than the US 
resolution limit, they can be considered as point scatterers in 
the acoustic field and their image is blurred by the point 
spread function (PSF) of the imaging system [12]. Sub-
diffraction imaging is a well-developed field in optical 
microscopy [13]-[16], where methods have been developed to 
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 overcome the same fundamental physics through the 
localization of many spatially isolated photo-activatable 
fluorophore signals. Initial in vitro work by ourselves [17] and 
others [18], have demonstrated the potential for microbubbles 
to be used in a similar way to achieve sub-diffraction US 
imaging at depths of up to 4 cm in phantoms. In this paper we 
present the use of this super-resolution technique in vivo. This 
uses an unmodified clinical US system in a standard contrast 
enhanced mode. In addition, since this technique utilizes 
microbubble contrast agents that have an intravascular 
rheology similar to that of red blood cells [19], we create a 
new technique to map blood velocity at super-resolution. For 
comparison, optical images as well as conventional contrast 
enhanced US images are displayed alongside the super-
resolved images. 
II. MATERIALS AND METHODS 
A. Ultrasound Equipment and Acquisition 
All data was acquired using a standard, unmodified Siemens 
Acuson Sequoia clinical US scanning system (Siemens, 
Issaquah, WA) using Cadence™ contrast pulse sequencing 
(CPS) mode [20]. This is a standard US imaging mode that is 
sensitive and specific to contrast agents based on the 
processing of receive signals to emphasize nonlinear bubble 
signals, while suppressing the linear contribution where tissue 
is predominant. A 15L8 linear array transducer was chosen for 
use in this experiment due to the suitability of a small probe 
size to the in vivo mouse ear model. This was used at an 
average transmit frequency of 6.5 MHz and a low transmit 
power equivalent to a mechanical index of 0.16. Data was 
acquired using the maximum frame rate and dynamic range 
settings available for this system of 25 Hz and 100 dB 
respectively. 
 
B. Ultrasound System Characterization  
Characterization of the PSF was performed to assess the 
diffraction limited resolution and localization precision of the 
US imaging system under ideal conditions. A 100 µm 
diameter brass wire was held horizontally between two fixings 
in a gas equilibrated water bath. The wire was positioned 
normal to the US image plane so that the cross-section of the 
wire was imaged to imitate a point scatterer. This was 
performed at depths of 0.5 cm, 0.75 cm, 1 cm and 1.25 cm 
from the transducer face to test the PSF over the range of 
depths imaged in vivo. Firstly, each frame was de-compressed 
to remove the logarithmic image scaling applied by the 
scanner acquisition software. The center of mass of the wire 
signal was then calculated for each frame, as well as the full 
width half maximum (FWHM) of the signal in the lateral and 
axial directions. The resolution of the US system was 
measured as the average FWHM over 100 frames in lateral 
and axial directions. The localization precision was measured 
to be the standard deviation of the measured center of mass 
over 100 frames.  
To account for the finite size of the wire in the measurement 
of the PSF we de-convolved the measured FWHM value by 
the finite size of the wire to obtain new values of the PSF 
FWHM. De-convolving, this becomes:  
 
 𝐹𝑊𝐻𝑀𝑥!"#$%&"'! =   𝐹𝑊𝐻𝑀𝑥!"#$!%! +   𝐹𝑊𝐻𝑀𝑥!"#! (1) 
  
  
 𝐹𝑊𝐻𝑀𝑥!"#=    𝐹𝑊𝐻𝑀𝑥!"#$%&"'! −   𝐹𝑊𝐻𝑀𝑥!"#$!%! (2) 
 
C. In Vivo Model 
All animal work was conducted under the authority of the 
UK Home Office project license as required by the Animals 
(Scientific Procedures) Act 1986. Mice were maintained in a 
minimal disease facility fully compliant with Home Office 
guidelines with food and water ad libitum. A 27 g, 8-week-
old, female, CD1 mouse was anaesthetized using isofluorane 
gas and monitored constantly.  
 
 
 
 
Fig. 1. Schematic diagram of imaging set-up. (a) Optical set-up where 
microscopic imaging was performed across the surface of the mouse ear. (b) 
US set-up consisting of the transducer positioned above the mouse ear such 
that the entire width was within the US lateral field of view. 
 
D. Optical Imaging 
One ear of the mouse was depilated by shaving and 
depilatory cream was applied to ensure visibility of the 
vascular structure for optical microscopy. The mouse was 
positioned on a light diffusing stage such that the ear was 
relatively flat against the surface of the stage (Fig. 1(a)). 
Optical images of the vascular structure were then acquired 
using a Wild Heerbrugg M650 (Switzerland) microscope and 
a SONY Handycam HDR SR12E (Japan) camera.  
 
E. Ultrasound Imaging 
The anaesthetized mouse was transferred to a heat mat and 
positioned with the prepared ear vertical to the surface, as 
shown in Fig. 1(b). The transducer was positioned above the 
 ear such that the entire width of the ear was within the lateral 
field of view and the length of the ear extended in the axial 
imaging direction. US gel was applied around the ear to cover 
the entire elevational imaging plane as well as to flatten the 
ear within the plane, and was applied above the ear in order to 
couple to the imaging device. 
A heparin flushed, 29G catheter was placed in the mouse 
tail vein. A suspension of SonoVue (Bracco Imaging SpA, 
Milan, Italy) microbubbles at 2.5× original concentration of 
original vial was administered using a syringe pump with an 
infusion rate of between 0.2-5.0 µl per minute to provide a 
bubble per frame density which ensured that a high proportion 
of the bubble signals in each frame were spatially isolated. 
The infusion rate was varied in response to visual inspection 
of the images in real time. An estimate suggests that the 
resulting bubble infusion rate per unit blood volume is in the 
range of ~1-10 times that used in conventional human contrast 
imaging [21] - [22]. The total injected volume did not exceed 
200 µl. The region around the mouse ear was defined on the 
US system at a depth of 0.6-1.5 cm and video data of 
microbubbles flowing through branching blood vessels in the 
mouse ear was captured directly to PC from the S-Video out 
via an analogue to digital capture device (Intensity Shuttle, 
Blackmagic Design). As a consequence, the frame rate of the 
acquired video sequence was limited to 25 fps. However, 
storage capacity was not restricted by the limited onboard 
hardware of the ultrasound system. Upon reaching the 
maximum injection volume, the anaesthetized mouse was 
culled.  
 
F. Microbubble Localization 
Algorithms were written in MATLAB (The MathWorks, 
Inc., Natick, MA) to process the acquired video data as 
follows. Firstly, all raw image frames were logarithmically 
decompressed. Then a region containing a constant scatter 
signal from the base of the ear was identified within a 
reference frame. The cross correlation of this region was then 
calculated between the reference frame and all subsequent 
frames in order to identify inter-frame motion. Breathing 
induced motion artifacts were then removed by excluding 
frames with an empirically determined cross-correlation value 
of less than 0.98. The remaining frames were then processed 
based on our previous work [17], where firstly frames which 
potentially contained a microbubble signal were identified by 
comparing the total intensity of the frame to an empirically 
determined threshold based on the characterization of the 
noise of the system. ‘Empty’ frames were added to a rolling 
background average, whereas potential bubble frames had the 
rolling background average subtracted from them. The rolling 
average was taken over n = 10 frames in order to remove the 
unwanted background signals due to static structures without 
removing slow moving bubbles. Potential bubble frames were 
then binarized using an intensity threshold, and the size of any 
connected regions in the image were compared to the expected 
PSF based on our initial characterization experiments in order 
to reject signals coming from noise or from multiple bubbles. 
This is because we cannot assume that the center of mass of 
signals from multiple separated unresolved microbubbles 
within a PSF sized volume are representative of the bubble 
location. The intensity-weighted center of mass of each 
spatially isolated microbubble signal was then calculated to 
obtain coordinates for the localized bubble position Cx, Cy.  
 
G. Super-Resolution Image Generation 
A script was written for generation of the final super-
resolution image. Here, each individual bubble localization 
was represented by a 2-D Gaussian profile centered at Cx, Cy 
with standard deviations, σx and σy, given by the average 
lateral and axial localization uncertainty of the PSF FWHM. 
The super-resolution map resulting from the sum of all the 
individual centroid localization distributions across all frames 
creates an image in which the displayed value is proportional 
to the chance of finding a microbubble positioned at that 
location.  
 
H. Microbubble Tracking 
Microbubble tracking algorithms were written in MATLAB 
to determine the flow velocity within the microvasculature. 
Firstly, microbubble signals deemed to be spatially isolated 
were identified in each frame as described in the microbubble 
localization program. For each frame n, individual 
microbubble signals were identified. The individual intensity 
cross correlations between each bubble signal in frame n and 
each of the bubble signals found in frame n-1 within a 400 
micrometer search window were then calculated and the 
maximum cross correlation was found for each signal in frame 
n. The search window size was defined to reject bubbles 
which far exceeded the expected red blood cell velocity in the 
ear [19]. A pair of signals were deemed to come from the 
same bubble if the maximum cross correlation exceeded an 
empirically determined threshold of 0.8. For each pair, a 
velocity vector was then calculated between Cxn, Cyn and Cxn-1, 
Cyn-1 and assigned to the centroid location Cxn, Cyn in frame n. 
 
I. Flow Velocity Image Generation 
To generate flow velocity images, the velocity vectors 𝑣! 
associated with each localized bubble position C = (Cx, Cy) are 
combined using a weighted spatial averaging approach. 
Firstly, for each velocity vector 𝑣! at C, all j centroids which 
exist within a neighborhood of radius r = 40 µm are identified. 
A weighting 𝑤! is then applied to each 𝑣!, given by 
 
 𝑤! =   𝑒! !!! ! (3) 
 
where 𝑑! is the distance from C to centroid Ci. The velocity 𝑣! 
is then given by the weighted sum of all neighborhood 
velocity distributions 
 
  𝑣! = 1𝑍 𝑤!𝑣!!!!! , (4) 
 
where Z is the normalization factor given by 
 
 𝑍 =    𝑤!!!!! . (5) 
 
The speed and direction components of velocity are then 
presented in separate images. Velocity vector components for 
each localization were displayed on the 95% confidence 
interval of the 2D Gaussian profile used to generate the super-
resolved images. In this way, noise present in the velocity data 
is reduced, while the underlying bubble positions are still 
localized to within the localization precision of the system. 
III. RESULTS 
 
To estimate the diffraction limited resolution under ideal 
conditions, we used a stationary point scatterer to measure the 
system PSF FWHM over the depth range 0.5-1.25 cm. As the 
backscatter from the scatterer was very strong we used a low 
gain and no additional TGC, hence the background noise is 
below the quantization level of the digitizer.  
Fig. 2 shows an example image of the wire cross-section at 
a depth of 1.25 cm, which provides the highest measured 
resolution for CPS imaging over the range investigated. Here, 
the resolution was measured to be a FWHM of 112 µm in the 
lateral and 94 µm in the axial direction. The localization 
precision of this point scatterer in the lateral and axial 
directions was found to be 6 and 2 µm respectively.  
 These results compare well with the estimated theoretical 
 
Fig. 2. Characterization of US imaging system. (a) shows an example 
logarithmically decompressed image of 100 µm diameter wire target cross-
section at 1.25 cm. (b) and (c) display example FWHMs in the lateral and 
axial directions respectively. 
resolution. Given that we are using CPS imaging, we assume 
that the effective US frequency is the mean of the fundamental 
and second harmonic, i.e. 9.75 MHz. Axially, this gives the 
FWHM of the spatial pulse length to be 80 µm. 
The expected lateral resolution is harder to estimate in the 
absence of proprietary knowledge of the exact transducer 
design - assuming a F/1 aperture gives a FWHM of 160 µm. 
Fig. 3(a) shows a typical CPS image frame of the mouse ear 
Fig. 3. Comparative images of mouse ear microvasculature using standard contrast enhanced US, single bubble localization method, and optical microscopy 
obtained using a surgical microscope. (a) A single high microbubble concentration image frame acquired using conventional Cadence™ CPS imaging mode. (b) 
Super-resolution image created as a probability density map where brightness represents the number of bubbles localized in a given location. (c) Corresponding 
optical image of the vasculature within the same mouse ear acquired in vivo. Scale bars, 1 mm. 
    
vasculature containing multiple bubble signals which are not 
spatially isolated – leading to an image that is similar to 
conventional contrast imaging. Here, diffraction limits 
visibility of the underlying structure and makes size estimation 
of the vessels impossible and the bubble concentration is too 
high to allow individual bubbles to be localized. Fig. 3(b) 
displays the super-resolved in vivo image produced using 
single bubble localization, where the branching vessel 
structures in the mouse ear are clearly visible across the entire 
imaging depth down to 1.5 cm. An optical image of the 
vascular structure in the mouse ear is shown in Fig. 3(c), 
where the vessel structure corresponds well to that visualized 
using our technique.  
To illustrate this, vessels were identified in the super-
resolution image as shown in Fig. 4(a), and shown at higher 
magnification in Fig. 4(b) and (c). Average vessel diameters of  
 
 
 
 
 
19 ± 2.8 µm (Fig. 4(d)), and 39 ± 1.4 µm (Fig. 4(e)) were 
measured at a depth of 0.8 cm and 0.9 cm respectively, 
compared to the measured diffraction limited lateral and axial 
resolutions of 112 µm and 94 µm. Corresponding 
measurements from an optical image for the vessel analyzed in 
Fig. 4(d) give an average vessel diameter of 24.4 ± 4.8 µm 
which is in good agreement to that measured using single 
bubble  localization (Fig. 5). 
Fig.6(a) shows the original super-resolution image, 
alongside color-encoded flow images of the vascular structure 
attained at super-resolution (Fig. 4(b) and (c)). Fig. 6(b) 
displays the directional component of velocity over 360° and 
Fig. 6(c) shows the speed variation for bubble flow within the 
vessels.  
Differentiation between flow direction and speed can 
separate the opposing blood flow into arteries and veins, and 
therefore enhance the visualization of objects within the image 
Fig. 4. Super-resolved vessel measurements. (a) Super-resolution image as shown in Fig. 3B, where the white boxes identify two vessels of interest, 
shown at higher magnification (b) and (c). Fig 4(d) and (e) show two average normalized line profiles across regions of 200 µm length (B1-B2 and 
C1-C2), as outlined in (b) and (c). The mean profile FWHM was 19 ± 2.8 µm and 39 ± 1.4 µm for the curves shown in (d) and (e) respectively. Scale 
bars, 2 mm (a), 500 µm (b, c).  
 
    
Fig. 5. Optical image profiles at 3 locations (M1-M3) across vessel shown in 
Fig. 4(b) and corresponding profiles in Fig. 4(d), where each profile spans 200 
µm of the length of the vessel. The mean FWHM of the optical profiles is 24.4 
± 4.8 µm. The pixel size of the optical images is 5.4 µm. 
 
which are not otherwise spatially separable. 
Fig. 7 shows one such example in more detail, where 
opposing flow directions (Fig. 7(a)) can be seen to correlate 
with two distinct speed distributions (Fig. 7(b)). This is shown 
in the speed profile along a 400 µm section of the vessel 
structure (Fig. 7(b)), which reveals a high speed at the vessel 
centers with decreasing speeds toward the vessel walls (Fig. 
7(c)). The peak average velocity in the artery is 3080 µm/s, 
and only 1850 µm/s in the vein. This higher speed arterial 
flow and slower flow present in veins can be observed 
throughout the vasculature (Fig. 8). 
 
 
 
Fig. 7. Regional velocity maps. (a) Magnified image section from Fig. 6B 
where what appeared initially to be one vessel can be differentiated into an 
adjacent artery and vein with opposing flows. (b) shows the corresponding 
speed of flow through the vessels, where speeds above 1500 µm/s are set to 
the maximum on the colorbar. The corresponding average flow profile over 
400 µm (white box) is shown in (c). In both, two vessel profiles can be clearly 
identified by a distinct slow flow separation, where faster flow is apparent in 
the centers of the vessels. Scale bar, 500 µm. 
 
Fig. 6. Super-resolution velocity maps. (a) Super-resolution image as shown in Fig. 3(b), and corresponding image displaying the direction of blood flow is shown 
in (b). (c) shows the corresponding speed of flow through the vessels, where speeds above 1500 µm/s are set to the maximum on the colorbar.  Scale bars, 1 mm. 
  
 
Fig. 8. Magnified image sections taken throughout the microvasculature from 
Fig. 6(b), showing vessels with opposing flow directions, and their 
corresponding average flow speed profiles across 400 µm (indicated by the 
white boxes). 
IV. DISCUSSION 
Using conventional CPS contrast imaging, the mouse 
vasculature cannot be observed since the branching structures 
are significantly smaller than even the optimal system PSF 
FWHM. However, by detecting and deconvolving spatially 
isolated scattering events and superimposing all the localized 
bubble positions onto a single map, vessel structures over 5-
times smaller than the optimal diffraction limited resolution 
were resolved. 
Some vessels appear more clearly in the super-resolution 
US image than in the optical image, and vice versa. Since the 
number of localizations in the super-resolution image is 
proportional to the likelihood of a bubble being present over 
the course of the observation, the concentration of 
microbubbles in the vessels dictates their visualization in the 
final image. In addition, variations in the position of the 
mouse ear in the elevational direction may cause some vessels 
to move out of the plane imaged by the US system. While we 
tried to ensure that the mouse ear was as flat as possible for 
both the optical and US imaging, the inherent differences 
between the two modalities mean that there will inevitably be 
some discrepancies between the two, i.e. small vessels on the 
far side of the ear from the surgical microscope used to 
acquire the optical image will not be clearly resolved. This is a 
limitation of the 2-D acquisition process and in the future, a 3-
D implementation of this technique will allow complex 
structures to be super-resolved in the elevational plane.  
A recent imaging technique called photo-acoustic 
tomography (PAT) has been developed which detects the 
acoustic waves generated from an object by optical absorption 
after being irradiated with pulsed or intensity modulated 
optical waves. This technique, and embodiments of it such as 
photo-acoustic microscopy (PAM), photo-acoustic computed 
tomography (PACT) and photo-acoustic endoscopy (PAE) 
have shown impressive 3-D renderings of microvascular 
structures in vivo [23]. This technique, however, suffers from 
the inherent compromise between achievable spatial resolution 
and depth penetration, with estimated optimal resolutions for 
optical resolution PAM (OR-PAM) of 5 µm laterally and 15 
µm axially, but with a limit of 0.7 mm penetration depth [24]. 
This can be improved to a depth of 50 mm with ultrasound 
array based PACT (UA-PACT), but with a considerable 
reduction in the achievable resolution to 800 µm laterally and 
300 µm axially [23], [25]-[26].  
Moreover, the technology has not yet been translated to the 
clinic and will require specialized equipment to enable this 
transition [23]. Our super-resolution technique detects 
microvasculature with a resolution of under 20 µm at imaging 
depths of > 1 cm and has been performed using standard 
equipment routinely used in clinical US scans, requiring only 
the image data. Microbubbles are approved for clinical use 
worldwide, and although not used routinely for clinical US 
scans, their use as a contrast imaging agent in diagnostics and 
therapeutics is continuing to grow. 
There are two main factors which influence the 
visualization of the vasculature in the final super-resolution 
images. Firstly, the spatial resolution is limited by the 
localization uncertainties σx and σy of the system since this 
determines the size of each Gaussian localization profile. 
Secondly, the density of localizations in the final image 
determines the signal to noise ratio in the rendered image. A 
reduced localization density gives less complete information 
about the spatial distribution of the bubble flow inside the 
structure. 
A fundamental compromise therefore exists between the 
exclusion criteria of bubble signals and the density of 
localizations in the final image. The strict inclusion of bubbles 
with only a narrow spectrum of sizes and intensities similar to 
that of our expected PSF should result in a sharper image with 
a higher resolution. However, the spatial distribution of 
localizations will be more sparse unless acquisition time or 
frame rate is increased. These are therefore key parameters for 
optimizing the performance of this technique in the future. 
‘The microbubble localization imaging approach requires 
that the microbubbles sample the entire microvascular 
structure. Therefore, increasing the detection frame rate will 
increase the microbubble localization density per second. 
However, if the flow rate in a particular vessel is sufficiently 
slow that a microbubble moves by less than the localization 
precision between frames, then no additional information is 
gained by further increasing the frame rate. Therefore, for 
optimal data collection, the US frame rate must be chosen 
according to the localization precision and the maximum 
microbubble velocity expected for a given sample. Currently, 
our processing algorithms can process up to 13 frames per 
second. In the future, optimization of our current processing 
algorithms will enable localizations to be plotted in each 
frame, and thus the final image to be built up in real time at 
higher frame rates. This technique would benefit from the 
development of automated or semi-automated processing 
which is consistent across patients. 
One possible modification of the technique may involve the 
use of mono-dispersed bubbles. These will have the same 
 fundamental frequency and should respond in a similar way to 
a specific ultrasound wave. Backscatter signals depend on the 
mechanical response of the bubble and the point spread 
function of the imaging system and should therefore be more 
uniform with a mono-dispersed bubble solution. However, due 
to a spatially variant PSF, there will still be some variation in 
signals across the field of view. 
The resolution of this technique is fundamentally limited by 
the achievable PSF localization precision; our characterization 
measurements suggest that this is 2 to 6 µm for the system 
used. The data acquired to achieve this super-resolution is the 
processed image output from a standard, unmodified clinical 
ultrasound system; this has been digitally and logarithmically 
compressed, as well as envelope detected by the system. Each 
of these processes could reduce the achievable precision. 
Using raw data, the read-out noise of the system would be the 
fundamental limit on localization precision of the US system. 
The localization algorithm employed may reject signals 
from bubble-wall interactions as they may not match the 
expected PSF. In future work we plan to use an optical 
microscope in combination with our acoustic set-up to 
optically visualize and acoustically locate the bubbles in a tube 
phantom; this will provide further insight into bubble 
interactions and velocities. 
The distribution of microbubble localization events is 
indicative of the concentration of microbubbles throughout the 
vessel, regardless of the flow profile. Coupled arteries and 
veins that are touching will have no spatial separation in 
super-resolved localization density maps, but can be 
distinguished by mapping the velocity. This has been shown in 
Fig. 8, where both speed profiles and bubble direction maps 
display a clear distinction between coupled vessels, with a 
clear dip in speed between vessels with opposing flow. This 
speed does not reduce to zero in any of the cases analyzed 
here. This could be due to a number of factors. First, speed 
and velocity vectors were associated with the 95% confidence 
interval around their localized position. Therefore, 
overlapping velocity vectors will likely be non-zero on 
average since only few microbubbles are included in each 
estimate. Secondly, the spatial averaging of the velocity 
vectors means that unless the bubbles in opposing vessels 
were travelling at exactly the opposite velocity in magnitude 
and direction, the overall average speed component will be 
non-zero. For example, the two vessels may not run precisely 
in parallel. 
The extension of this technique to extract flow velocity data 
from bubble localizations widens the application of the 
technique to include those of Doppler imaging, with the 
significant advantage of having flow information at super-
resolution. Direction and speed images provide a higher level 
of information to the already super-resolved structures, 
enabling visualization of even smaller structures, and 
dynamics within the vessels. The potential to non-invasively 
image the microvascular flow deep within the body with US 
has widespread implications for the detection, diagnosis and 
management of many diseases. For example, 
neovascularization and red blood cell velocity changes, which 
can be indicative of early stage ischemia, tumor growth and 
wide ranging vascular diseases [4], [27]. 
V. CONCLUSION 
Our results demonstrate that single bubble localization can 
produce acoustic super-resolution and super-resolved flow 
velocity images in vivo from standard image data acquired by 
an unmodified clinical US system using simple post-
processing localization algorithms.  This approach can be 
applied to achieve an enhanced spatial resolution for US 
systems operating at any transmit and/or receive frequency. 
With the development of existing motion correction 
techniques, e.g. [28]-[29], as well as fast 3-D US acquisition 
[30], this technique has the potential to greatly enhance the 
resolution achieved when imaging vasculature deep within the 
body.  
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